Skip to main content
. 2009 Dec;3(6 Suppl 4):S188–S192.

Table 1.

Published results of BCG treatment for T1 G3 bladder cancer

Author No. patients Follow-up, mos. Recurrence, % Progression, % Disease-specific survival rate, %
Pfister, 199549 26 54 50 27 92
Mack, 199550 32 57 29 17 100
Pansadoro, 199551 64 42 28 12 98
Pansadoro, 200252 81 76 33 15 94
Hurle, 199653 51 33 45 14 N/A
Hurle, 199948 51 85 N/A 18 86
Lebret, 199854 35 45 43 20 94
Gohji, 199955 45 63 36 4 100
Brake, 200056 44 43 27 16 89
Patard, 200157 50 65 52 22 86
Kulkarni, 200258 69 48 46 12 94
Griffiths, 200259 75 41 N/A 49 59
Bogdanovic, 200260 43 53 28 16 95
Peyromaure, 200361 57 53 42 23 88
Shahin, 200362 92 64 70 33 77
Cheng, 200463 36 46 44 25 86
Weighted totals 800 56 43% 22% 88%

N/A = not available; BCG = bacillus Calmette-Guérin.